Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR | Q13258 | 13/20 | 0.63 |
| ▸ | MMP3 | P08254 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.42 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.42 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.39 |
| ▸ | USP7 | Q93009 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13894999 | 0.85 | ALDH1A1 (0.47) | PTGDRALDH1A1SMN1; SMN2PIK3CAPIK3CB | |
| SCHEMBL9912189 | 0.84 | BCHE (0.47) | PTGDRALDH1A1SMN1; SMN2PIK3CAPIK3CB | |
| SCHEMBL9912207 | 0.81 | PTGDR (0.51) | PTGDRMMP3PIK3CAPIK3CBPIK3CG | |
| SCHEMBL9912210 | 0.80 | ALDH1A1 (0.44) | PTGDRALDH1A1SMN1; SMN2PIK3CAPIK3CB | |
| SCHEMBL9912204 | 0.80 | PTGDR (0.56) | PTGDRALDH1A1SMN1; SMN2PIK3CAPIK3CB | |
| SCHEMBL9912237 | 0.79 | PTGDR (0.52) | PTGDRALDH1A1SMN1; SMN2PIK3CAPIK3CB | |
| SCHEMBL4491413 | 0.77 | PTGDR (1.00) | PTGDR | |
| SCHEMBL9912281 | 0.77 | BRAF (0.61) | PTGDRALDH1A1SMN1; SMN2 | |
| SCHEMBL9912208 | 0.77 | PTGDR (0.57) | PTGDRALDH1A1SMN1; SMN2PIK3CAPIK3CB | |
| SCHEMBL9912203 | 0.75 | PTGDR (0.66) | PTGDRALDH1A1SMN1; SMN2PIK3CAPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8193183-B2 | 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists | AVENTIS PHARMACEUTICALS INC. (US) | 2012-06-05 | — | — | US | disclosed |